Valeriia Buzova

Valeriia Buzova earned a B.Sc. in Biotechnology from M.V. Lomonosov Moscow Institute and an M.Sc. in Innovation Management from Lomonosov Moscow State University. Her early research focused on investigating antibiotic-resistance mechanisms in nosocomial Gram-negative bacteria, vaccine development against Streptococcus and drug discovery for COVID-19. She currently works at SkyLab AG (Switzerland), developing innovative oral-care systems, targeting enamel whitening, remineralization, and cariogenic-bacteria inhibition. Valeriia Buzova is an author of four scientific articles and three international patent applications, she has contributed to the launch of over ten cosmetic products featuring her innovations.